Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 786

1.

Disasters, children and the kidneys.

Sever MS, Sever L, Vanholder R.

Pediatr Nephrol. 2019 Aug 17. doi: 10.1007/s00467-019-04310-x. [Epub ahead of print] Review.

PMID:
31422466
2.

Identifying critically important vascular access outcomes for trials in haemodialysis: an international survey with patients, caregivers and health professionals.

Viecelli AK, Howell M, Tong A, Teixeira-Pinto A, O'Lone E, Ju A, Craig JC, Hooi LS, Lee T, Lok CE, Polkinghorne KR, Quinn RR, Vachharajani TJ, Vanholder R, Zuo L, Tordoir J, Pecoits-Filho R, Yuo T, Kopperschmidt P, Smith R, Irish AB, Mori TA, Pascoe EM, Johnson DW, Hawley CM.

Nephrol Dial Transplant. 2019 Aug 1. pii: gfz148. doi: 10.1093/ndt/gfz148. [Epub ahead of print]

PMID:
31369099
3.

Nephrology and Public Policy Committee propositions to stimulate research collaboration in adults and children in Europe.

Massy ZA, Caskey FJ, Finne P, Harambat J, Jager KJ, Nagler E, Stengel B, Sever MS, Vanholder R, Blankestijn PJ, Bruchfeld A, Capasso G, Fliser D, Fouque D, Goumenos D, Soler MJ, Rychlík I, Spasovski G, Stevens K, Wanner C, Zoccali C.

Nephrol Dial Transplant. 2019 Sep 1;34(9):1616. doi: 10.1093/ndt/gfz154. No abstract available.

PMID:
31361317
4.

Haemodiafiltration does not lower protein-bound uraemic toxin levels compared with haemodialysis in a paediatric population.

Snauwaert E, Van Biesen W, Raes A, Glorieux G, Vande Walle J, Roels S, Vanholder R, Askiti V, Azukaitis K, Bayazit A, Canpolat N, Fischbach M, Saoussen K, Litwin M, Obrycki L, Paglialonga F, Ranchin B, Samaille C, Schaefer F, Schmitt CP, Spasojevic B, Stefanidis CJ, Shroff R, Eloot S.

Nephrol Dial Transplant. 2019 Jul 30. pii: gfz132. doi: 10.1093/ndt/gfz132. [Epub ahead of print]

PMID:
31361315
5.

Clinical practice guideline on peri- and postoperative care of arteriovenous fistulas and grafts for haemodialysis in adults.

Gallieni M, Hollenbeck M, Inston N, Kumwenda M, Powell S, Tordoir J, Al Shakarchi J, Berger P, Bolignano D, Cassidy D, Chan TY, Dhondt A, Drechsler C, Ecder T, Finocchiaro P, Haller M, Hanko J, Heye S, Ibeas J, Jemcov T, Kershaw S, Khawaja A, Labriola L, Lomonte C, Malovrh M, Marti I Monros A, Matthew S, McGrogan D, Meyer T, Mikros S, Nistor I, Planken N, Roca-Tey R, Ross R, Troxler M, van der Veer S, Vanholder R, Vermassen F, Welander G, Wilmink T, Koobasi M, Fox J, Van Biesen W, Nagler E.

Nephrol Dial Transplant. 2019 Jul 19. pii: gfz153. doi: 10.1093/ndt/gfz153. [Epub ahead of print] No abstract available.

PMID:
31325303
6.

Contribution of the uremic milieu to an increased pro-inflammatory monocytic phenotype in chronic kidney disease.

Borges Bonan N, Schepers E, Pecoits-Filho R, Dhondt A, Pletinck A, De Somer F, Vanholder R, Van Biesen W, Moreno-Amaral A, Glorieux G.

Sci Rep. 2019 Jul 15;9(1):10236. doi: 10.1038/s41598-019-46724-5.

7.

Nephrology and Public Policy Committee propositions to stimulate research collaboration in adults and children in Europe.

Massy ZA, Caskey FJ, Finne P, Harambat J, Jager KJ, Nagler E, Stengel B, Sever MS, Vanholder R, Blankestijn PJ, Bruchfeld A, Capasso G, Fliser D, Fouque D, Goumenos D, Soler MJ, Rychlík I, Spasovski G, Stevens K, Wanner C, Zoccali C.

Nephrol Dial Transplant. 2019 Sep 1;34(9):1469-1480. doi: 10.1093/ndt/gfz089.

PMID:
31197325
8.

Clinical practice guideline on peri- and postoperative care of arteriovenous fistulas and grafts for haemodialysis in adults.

Gallieni M, Hollenbeck M, Inston N, Kumwenda M, Powell S, Tordoir J, Al Shakarchi J, Berger P, Bolignano D, Cassidy D, Chan TY, Dhondt A, Drechsler C, Ecder T, Finocchiaro P, Haller M, Hanko J, Heye S, Ibeas J, Jemcov T, Kershaw S, Khawaja A, Labriola L, Lomonte C, Malovrh M, Marti I Monros A, Matthew S, McGrogan D, Meyer T, Mikros S, Nistor I, Planken N, Roca-Tey R, Ross R, Troxler M, van der Veer S, Vanholder R, Vermassen F, Welander G, Wilmink T, Koobasi M, Fox J, Van Biesen W, Nagler E.

Nephrol Dial Transplant. 2019 Jun 1;34(Supplement_2):ii1-ii42. doi: 10.1093/ndt/gfz072. No abstract available.

PMID:
31192372
9.

The new European Renal Best Practice guideline on arteriovenous access: why worthwhile to read.

Vanholder R, Van Biesen W, Fox JG, Nagler EV.

Nephrol Dial Transplant. 2019 Jul 1;34(7):1071-1074. doi: 10.1093/ndt/gfz118. No abstract available.

PMID:
31190056
10.

A swan song for Kt/Vurea.

Vanholder R, Van Biesen W, Lameire N.

Semin Dial. 2019 Sep;32(5):424-437. doi: 10.1111/sdi.12811. Epub 2019 Apr 25. Review.

PMID:
31025455
11.

Uremic Toxin Concentrations are Related to Residual Kidney Function in the Pediatric Hemodialysis Population.

Snauwaert E, Holvoet E, Van Biesen W, Raes A, Glorieux G, Vande Walle J, Roels S, Vanholder R, Askiti V, Azukaitis K, Bayazit A, Canpolat N, Fischbach M, Godefroid N, Krid S, Litwin M, Obrycki L, Paglialonga F, Ranchin B, Samaille C, Schaefer F, Schmitt CP, Spasojevic B, Stefanidis CJ, Van Dyck M, Van Hoeck K, Collard L, Eloot S, Shroff R.

Toxins (Basel). 2019 Apr 24;11(4). pii: E235. doi: 10.3390/toxins11040235.

12.

Serum levels of miR-126 and miR-223 and outcomes in chronic kidney disease patients.

Fourdinier O, Schepers E, Metzinger-Le Meuth V, Glorieux G, Liabeuf S, Verbeke F, Vanholder R, Brigant B, Pletinck A, Diouf M, Burtey S, Choukroun G, Massy ZA, Metzinger L; European Uremic Toxin Work Group-EUTox.

Sci Rep. 2019 Mar 14;9(1):4477. doi: 10.1038/s41598-019-41101-8.

13.

Disaster medicine and response: Optimizing life-saving potential.

Sever MS, Remuzzi G, Vanholder R.

Am J Disaster Med. 2018 Fall;13(4):253-264. doi: 10.5055/ajdm.2018.0305. Review.

PMID:
30821339
14.

How to increase kidney transplant activity throughout Europe-an advocacy review by the European Kidney Health Alliance.

Vanholder R, Stel VS, Jager KJ, Lameire N, Loud F, Oberbauer R, de Jong RW, Zoccali C.

Nephrol Dial Transplant. 2019 Jan 9. doi: 10.1093/ndt/gfy390. [Epub ahead of print]

PMID:
30629203
15.

Evolution of protein-bound uremic toxins indoxyl sulphate and p-cresyl sulphate in acute kidney injury.

Veldeman L, Vanmassenhove J, Van Biesen W, Massy ZA, Liabeuf S, Glorieux G, Vanholder R.

Int Urol Nephrol. 2019 Feb;51(2):293-302. doi: 10.1007/s11255-018-2056-x. Epub 2019 Jan 2.

PMID:
30604232
16.

Association between Protein-Bound Uremic Toxins and Asymptomatic Cardiac Dysfunction in Patients with Chronic Kidney Disease.

Chinnappa S, Tu YK, Yeh YC, Glorieux G, Vanholder R, Mooney A.

Toxins (Basel). 2018 Dec 5;10(12). pii: E520. doi: 10.3390/toxins10120520.

17.

An International Analysis of Dialysis Services Reimbursement.

van der Tol A, Lameire N, Morton RL, Van Biesen W, Vanholder R.

Clin J Am Soc Nephrol. 2019 Jan 7;14(1):84-93. doi: 10.2215/CJN.08150718. Epub 2018 Dec 13.

PMID:
30545819
18.

Subclinical AKI: ready for primetime in clinical practice?

Vanmassenhove J, Van Biesen W, Vanholder R, Lameire N.

J Nephrol. 2019 Feb;32(1):9-16. doi: 10.1007/s40620-018-00566-y. Epub 2018 Dec 6. Review.

PMID:
30523562
19.

Author Correction: Lipid management in patients with chronic kidney disease.

Ferro CJ, Mark PB, Kanbay M, Sarafidis P, Heine GH, Rossignol P, Massy ZA, Mallamaci F, Valdivielso JM, Malyszko J, Verhaar MC, Ekart R, Vanholder R, London G, Ortiz A, Zoccali C.

Nat Rev Nephrol. 2019 Feb;15(2):121. doi: 10.1038/s41581-018-0099-y.

PMID:
30538326
20.

Gut microbiota dynamics and uraemic toxins: one size does not fit all.

Joossens M, Faust K, Gryp T, Nguyen ATL, Wang J, Eloot S, Schepers E, Dhondt A, Pletinck A, Vieira-Silva S, Falony G, Vaneechoutte M, Vanholder R, Van Biesen W, Huys GRB, Raes J, Glorieux G.

Gut. 2018 Nov 21. pii: gutjnl-2018-317561. doi: 10.1136/gutjnl-2018-317561. [Epub ahead of print] No abstract available.

21.

Lipid management in patients with chronic kidney disease.

Ferro CJ, Mark PB, Kanbay M, Sarafidis P, Heine GH, Rossignol P, Massy ZA, Mallamaci F, Valdivielso JM, Malyszko J, Verhaar MC, Ekart R, Vanholder R, London G, Ortiz A, Zoccali C.

Nat Rev Nephrol. 2018 Dec;14(12):727-749. doi: 10.1038/s41581-018-0072-9. Review. Erratum in: Nat Rev Nephrol. 2019 Feb;15(2):121.

PMID:
30361677
22.

Treating potassium disturbances: kill the killers but avoid overkill.

Vanholder R, Van Biesen W, Nagler EV.

Acta Clin Belg. 2019 Aug;74(4):215-228. doi: 10.1080/17843286.2018.1531206. Epub 2018 Oct 24.

PMID:
30353786
23.

Introduction to the Toxins Special Issue on "Novel Issues in Uremic Toxicity".

Vanholder R.

Toxins (Basel). 2018 Sep 25;10(10). pii: E388. doi: 10.3390/toxins10100388. No abstract available.

24.

Gut-Derived Metabolites and Chronic Kidney Disease: The Forest (F)or the Trees?

Vanholder R, Glorieux G.

Clin J Am Soc Nephrol. 2018 Sep 7;13(9):1311-1313. doi: 10.2215/CJN.08200718. Epub 2018 Aug 7. No abstract available.

25.

Association between serum ferritin and mortality: findings from the USA, Japan and European Dialysis Outcomes and Practice Patterns Study.

Karaboyas A, Morgenstern H, Pisoni RL, Zee J, Vanholder R, Jacobson SH, Inaba M, Loram LC, Port FK, Robinson BM.

Nephrol Dial Transplant. 2018 Dec 1;33(12):2234-2244. doi: 10.1093/ndt/gfy190.

26.

Interventions for chronic non-hypovolaemic hypotonic hyponatraemia.

Nagler EV, Haller MC, Van Biesen W, Vanholder R, Craig JC, Webster AC.

Cochrane Database Syst Rev. 2018 Jun 28;6:CD010965. doi: 10.1002/14651858.CD010965.pub2. Review.

27.

Deleting Death and Dialysis: Conservative Care of Cardio-Vascular Risk and Kidney Function Loss in Chronic Kidney Disease (CKD).

Vanholder R, Van Laecke S, Glorieux G, Verbeke F, Castillo-Rodriguez E, Ortiz A.

Toxins (Basel). 2018 Jun 12;10(6). pii: E237. doi: 10.3390/toxins10060237. Review.

28.

Haste makes waste-Should current guideline recommendations for initiation of renal replacement therapy for acute kidney injury be changed?

Vanmassenhove J, Vanholder R, Van Biesen W, Lameire N.

Semin Dial. 2018 May;31(3):204-208. doi: 10.1111/sdi.12693. Epub 2018 Apr 10. Review.

PMID:
29635792
29.

Increased urinary osmolyte excretion indicates chronic kidney disease severity and progression rate.

Gil RB, Ortiz A, Sanchez-Niño MD, Markoska K, Schepers E, Vanholder R, Glorieux G, Schmitt-Kopplin P, Heinzmann SS.

Nephrol Dial Transplant. 2018 Dec 1;33(12):2156-2164. doi: 10.1093/ndt/gfy020.

PMID:
29554320
30.

A plea for more uremic toxin research in children with chronic kidney disease.

Snauwaert E, Van Biesen W, Raes A, Glorieux G, Vanholder R, Vande Walle J, Eloot S.

Pediatr Nephrol. 2018 Jun;33(6):921-924. doi: 10.1007/s00467-018-3920-8. Epub 2018 Mar 2. No abstract available.

PMID:
29500629
31.

Report of the Standardized Outcomes in Nephrology-Hemodialysis (SONG-HD) Consensus Workshop on Establishing a Core Outcome Measure for Hemodialysis Vascular Access.

Viecelli AK, Tong A, O'Lone E, Ju A, Hanson CS, Sautenet B, Craig JC, Manns B, Howell M, Chemla E, Hooi LS, Johnson DW, Lee T, Lok CE, Polkinghorne KR, Quinn RR, Vachharajani T, Vanholder R, Zuo L, Hawley CM; SONG-HD Vascular Access Workshop Investigators.

Am J Kidney Dis. 2018 May;71(5):690-700. doi: 10.1053/j.ajkd.2017.12.003. Epub 2018 Feb 23. Review.

PMID:
29478866
32.

Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update.

Vanholder R, Pletinck A, Schepers E, Glorieux G.

Toxins (Basel). 2018 Jan 8;10(1). pii: E33. doi: 10.3390/toxins10010033. Review.

33.

Caring for Migrants and Refugees With End-Stage Kidney Disease in Europe.

Van Biesen W, Vanholder R, Ernandez T, Drewniak D, Luyckx V.

Am J Kidney Dis. 2018 May;71(5):701-709. doi: 10.1053/j.ajkd.2017.10.015. Epub 2017 Dec 21. Review.

PMID:
29274918
34.

Vascular Access Outcomes Reported in Maintenance Hemodialysis Trials: A Systematic Review.

Viecelli AK, O'Lone E, Sautenet B, Craig JC, Tong A, Chemla E, Hooi LS, Lee T, Lok C, Polkinghorne KR, Quinn RR, Vachharajani T, Vanholder R, Zuo L, Irish AB, Mori TA, Pascoe EM, Johnson DW, Hawley CM.

Am J Kidney Dis. 2018 Mar;71(3):382-391. doi: 10.1053/j.ajkd.2017.09.018. Epub 2017 Dec 6.

PMID:
29203125
35.

Points of Concern in Post Acute Kidney Injury Management.

Vanmassenhove J, Vanholder R, Lameire N.

Nephron. 2018;138(2):92-103. doi: 10.1159/000484146. Epub 2017 Nov 2.

36.

Prediction of Chronic Kidney Disease Stage 3 by CKD273, a Urinary Proteomic Biomarker.

Pontillo C, Zhang ZY, Schanstra JP, Jacobs L, Zürbig P, Thijs L, Ramírez-Torres A, Heerspink HJL, Lindhardt M, Klein R, Orchard T, Porta M, Bilous RW, Charturvedi N, Rossing P, Vlahou A, Schepers E, Glorieux G, Mullen W, Delles C, Verhamme P, Vanholder R, Staessen JA, Mischak H, Jankowski J.

Kidney Int Rep. 2017 Nov;2(6):1066-1075. doi: 10.1016/j.ekir.2017.06.004.

37.

Mortality risk in patients on hemodiafiltration versus hemodialysis: a 'real-world' comparison from the DOPPS.

Locatelli F, Karaboyas A, Pisoni RL, Robinson BM, Fort J, Vanholder R, Rayner HC, Kleophas W, Jacobson SH, Combe C, Port FK, Tentori F.

Nephrol Dial Transplant. 2018 Apr 1;33(4):683-689. doi: 10.1093/ndt/gfx277.

38.

Spontaneous variability of pre-dialysis concentrations of uremic toxins over time in stable hemodialysis patients.

Eloot S, Van Biesen W, Roels S, Delrue W, Schepers E, Dhondt A, Vanholder R, Glorieux G.

PLoS One. 2017 Oct 10;12(10):e0186010. doi: 10.1371/journal.pone.0186010. eCollection 2017.

39.

p-Cresyl glucuronide is a major metabolite of p-cresol in mouse: in contrast to p-cresyl sulphate, p-cresyl glucuronide fails to promote insulin resistance.

Koppe L, Alix PM, Croze ML, Chambert S, Vanholder R, Glorieux G, Fouque D, Soulage CO.

Nephrol Dial Transplant. 2017 Dec 1;32(12):2000-2009. doi: 10.1093/ndt/gfx089.

PMID:
28992089
40.

Further approaches to reduce the cost of renal replacement therapy.

Vanholder R, Annemans L, Brown E, Gansevoort R, Gout-Zwart JJ, Lameire N, Morton RL, Oberbauer R, Postma MJ, Tonelli M, Van Biesen W, Zoccali C; European Kidney Health Alliance.

Nat Rev Nephrol. 2017 Nov;13(11):720. doi: 10.1038/nrneph.2017.136. Epub 2017 Sep 25. No abstract available.

PMID:
28944776
41.

Accumulation of uraemic toxins is reflected only partially by estimated GFR in paediatric patients with chronic kidney disease.

Snauwaert E, Van Biesen W, Raes A, Holvoet E, Glorieux G, Van Hoeck K, Van Dyck M, Godefroid N, Vanholder R, Roels S, Walle JV, Eloot S.

Pediatr Nephrol. 2018 Feb;33(2):315-323. doi: 10.1007/s00467-017-3802-5. Epub 2017 Sep 22.

PMID:
28939943
42.

The Place of Large Pore Membranes in the Treatment Portfolio of Patients on Hemodialysis.

Van Biesen W, Vanholder R, Schepers E, Glorieux G, Dhondt A, Eloot S.

Contrib Nephrol. 2017;191:168-177. doi: 10.1159/000479265. Epub 2017 Sep 14. Review.

PMID:
28910800
43.

Effect of Magnesium Supplements on Insulin Secretion After Kidney Transplantation: A Randomized Controlled Trial.

Van Laecke S, Caluwe R, Huybrechts I, Nagler EV, Vanholder R, Peeters P, Van Vlem B, Van Biesen W.

Ann Transplant. 2017 Aug 29;22:524-531.

44.

Hyponatraemia diagnosis and treatment clinical practice guidelines.

Spasovski G, Vanholder R, Allolio B, Annane D, Ball S, Bichet D, Decaux G, Fenske W, Hoorn EJ, Ichai C, Joannidis M, Soupart A, Zietse R, Haller M, van der Veer S, van Biesen W, Nagler E, Gonzalez-Espinoza L, Ortiz A; Hyponatraemia Guideline Development Group.

Nefrologia. 2017 Jul - Aug;37(4):370-380. doi: 10.1016/j.nefro.2017.03.021. Epub 2017 Jun 12. English, Spanish.

45.

Reducing the costs of chronic kidney disease while delivering quality health care: a call to action.

Vanholder R, Annemans L, Brown E, Gansevoort R, Gout-Zwart JJ, Lameire N, Morton RL, Oberbauer R, Postma MJ, Tonelli M, Biesen WV, Zoccali C; European Kidney Health Alliance.

Nat Rev Nephrol. 2017 Jul;13(7):393-409. doi: 10.1038/nrneph.2017.63. Epub 2017 May 30. Review.

PMID:
28555652
46.

Early and asymptomatic cardiac dysfunction in chronic kidney disease.

Chinnappa S, White E, Lewis N, Baldo O, Tu YK, Glorieux G, Vanholder R, El Nahas M, Mooney A.

Nephrol Dial Transplant. 2018 Mar 1;33(3):450-458. doi: 10.1093/ndt/gfx064.

47.

"Uremic Toxin" Section in the Journal Toxins: A Powerful Tool to Bundle and Advance Knowledge on Uremia.

Vanholder R.

Toxins (Basel). 2017 May 18;9(5). pii: E170. doi: 10.3390/toxins9050170.

48.

The systemic nature of CKD.

Zoccali C, Vanholder R, Massy ZA, Ortiz A, Sarafidis P, Dekker FW, Fliser D, Fouque D, Heine GH, Jager KJ, Kanbay M, Mallamaci F, Parati G, Rossignol P, Wiecek A, London G; European Renal and Cardiovascular Medicine (EURECA-m) Working Group of the European Renal Association – European Dialysis Transplantation Association (ERA-EDTA).

Nat Rev Nephrol. 2017 Jun;13(6):344-358. doi: 10.1038/nrneph.2017.52. Epub 2017 Apr 24. Review.

PMID:
28435157
49.

Urea and chronic kidney disease: the comeback of the century? (in uraemia research).

Vanholder R, Gryp T, Glorieux G.

Nephrol Dial Transplant. 2018 Jan 1;33(1):4-12. doi: 10.1093/ndt/gfx039. Review.

PMID:
28407121
50.

Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH).

Sarafidis PA, Persu A, Agarwal R, Burnier M, de Leeuw P, Ferro CJ, Halimi JM, Heine GH, Jadoul M, Jarraya F, Kanbay M, Mallamaci F, Mark PB, Ortiz A, Parati G, Pontremoli R, Rossignol P, Ruilope L, Van der Niepen P, Vanholder R, Verhaar MC, Wiecek A, Wuerzner G, London GM, Zoccali C.

Nephrol Dial Transplant. 2017 Apr 1;32(4):620-640. doi: 10.1093/ndt/gfw433. Review.

PMID:
28340239

Supplemental Content

Loading ...
Support Center